{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:56:59Z","timestamp":1790657819076,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s13300-026-01904-1","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:59:05Z","timestamp":1787648345000},"page":"1559-1577","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Complex Interplay Between Dyslipidemic Subjects Living with Type 2 Diabetes and Metabolic Syndrome and Statin Treatment: A Reflection on Adherence and Persistence in the Real World"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8917-5314","authenticated-orcid":false,"given":"Felice","family":"Strollo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5057-9650","authenticated-orcid":false,"given":"Giuseppina","family":"Guarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8154-287X","authenticated-orcid":false,"given":"Ersilia","family":"Satta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6866-4796","authenticated-orcid":false,"given":"Giuseppe","family":"Caccavale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5343-3457","authenticated-orcid":false,"given":"Maria","family":"Chiarello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4163-0977","authenticated-orcid":false,"given":"Maria Carla","family":"Sibilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5812-7016","authenticated-orcid":false,"given":"Carmine","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1353-8844","authenticated-orcid":false,"given":"Roberta","family":"Di Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9809-8708","authenticated-orcid":false,"given":"Rosina","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3960-9270","authenticated-orcid":false,"given":"Raffaele","family":"Marfella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9059-6121","authenticated-orcid":false,"given":"Sandro","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"1904_CR1","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. Cardiovascular disease and risk management: standards of care in diabetes-2024. Diabetes Care. 2024;47(1):S179\u2013S218. https:\/\/doi.org\/10.2337\/dc24-S010.","DOI":"10.2337\/dc24-S010"},{"issue":"9493","key":"1904_CR2","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","volume":"366","author":"C Baigent","year":"2005","unstructured":"Baigent C, Keech A, Kearney P, Blackwell L, Buck G, Emberson J, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366(9493):1267\u201378. https:\/\/doi.org\/10.1016\/S0140-6736(05)67394-1.","journal-title":"Lancet"},{"issue":"32","key":"1904_CR3","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1093\/eurheartj\/ehw628","volume":"38","author":"A Vonbank","year":"2017","unstructured":"Vonbank A, Agewall S, Kjeldsen KP, et al. Comprehensive efforts to increase adherence to statin therapy. Eur Heart J. 2017;38(32):2473\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/ehw628.","journal-title":"Eur Heart J"},{"issue":"6","key":"1904_CR4","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/j.1365-2125.2006.02828.x","volume":"63","author":"MH Bouchard","year":"2007","unstructured":"Bouchard MH, Dragomir A, Blais L, et al. Impact of adherence to statins on coronary artery disease in primary prevention. Br J Clin Pharmacol. 2007;63(6):698\u2013708. https:\/\/doi.org\/10.1111\/j.1365-2125.2006.02828.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"1904_CR5","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00228-009-0673-0","volume":"65","author":"S Perreault","year":"2009","unstructured":"Perreault S, Dragomir A, Blais L, et al. Impact of better adherence to statin agents in the primary prevention of coronary artery disease. Eur J Clin Pharmacol. 2009;65(10):1013\u201324. https:\/\/doi.org\/10.1007\/s00228-009-0673-0.","journal-title":"Eur J Clin Pharmacol"},{"issue":"18","key":"1904_CR6","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1517\/14656560903383021","volume":"10","author":"TR Bates","year":"2009","unstructured":"Bates TR, Connaughton VM, Watts GF. Non-adherence to statin therapy: a major challenge for preventive cardiology. Expert Opin Pharmacother. 2009;10(18):2973\u201385. https:\/\/doi.org\/10.1517\/14656560903383021.","journal-title":"Expert Opin Pharmacother"},{"key":"1904_CR7","unstructured":"WHO. The 11th revision of the international classification of diseases (ICD-11). 2024. https:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA72\/A72_29-en.pdf. Accessed 26 Nov 2024."},{"key":"1904_CR8","volume-title":"Adherence to long-term therapies: policy for action: meeting report, 4\u20135 June 2001","author":"E Sabat\u00e9","year":"2001","unstructured":"Sabat\u00e9 E, World Health Organization. Adherence to long-term therapies: policy for action: meeting report, 4\u20135 June 2001. Geneva: World Health Organization; 2001."},{"key":"1904_CR9","unstructured":"Guidelines on the health record. June 4 (2015). https:\/\/www.garanteprivacy.it\/web\/guest\/home\/docweb\/-\/docweb-display\/docweb\/4091542. Accessed 20 Feb 2024."},{"issue":"3","key":"1904_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/cpf.12307","volume":"37","author":"MN Baranauskas","year":"2017","unstructured":"Baranauskas MN, Johnson KE, Juvancic-Heltzel JA, Kappler RM, Richardson L, Jamieson S, et al. Seven-site versus three-site method of body composition using BodyMetrix ultrasound compared to dual-energy X-ray absorptiometry. Clin Physiol Funct Imag. 2017;37(3):317\u201321. https:\/\/doi.org\/10.1111\/cpf.12307.","journal-title":"Clin Physiol Funct Imag"},{"issue":"2","key":"1904_CR11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.clinthera.2009.02.021","volume":"31","author":"FH Gwadry-Sridhar","year":"2009","unstructured":"Gwadry-Sridhar FH, Manias E, Zhang Y, et al. A framework for planning and critiquing medication compliance and persistence research using prospective study designs. Clin Ther. 2009;31(2):421\u201335. https:\/\/doi.org\/10.1016\/j.clinthera.2009.02.021.","journal-title":"Clin Ther"},{"issue":"6","key":"1904_CR12","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s11886-011-0221-2","volume":"13","author":"A Mauskop","year":"2011","unstructured":"Mauskop A, Borden WB. Predictors of statin adherence. Curr Cardiol Rep. 2011;13(6):553\u20138. https:\/\/doi.org\/10.1007\/s11886-011-0221-2.","journal-title":"Curr Cardiol Rep"},{"issue":"4","key":"1904_CR13","first-page":"6","volume":"46","author":"M Alrais","year":"2021","unstructured":"Alrais M. Improving statin adherence in patients at risk for cardiovascular disease. US Pharm. 2021;46(4):6\u201312.","journal-title":"US Pharm"},{"key":"1904_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.trsl.2017.01.001.PMID:28130064;PMCID:PMC5393930","volume":"183","author":"JD Tune","year":"2017","unstructured":"Tune JD, Goodwill AG, Sassoon DJ, Mather KJ. Cardiovascular consequences of metabolic syndrome. Transl Res. 2017;183:57\u201370. https:\/\/doi.org\/10.1016\/j.trsl.2017.01.001.PMID:28130064;PMCID:PMC5393930.","journal-title":"Transl Res"},{"issue":"8 Suppl 3","key":"1904_CR15","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/MLR.0b013e31829b1d2a","volume":"51","author":"MA Raebel","year":"2013","unstructured":"Raebel MA, Schmittdiel J, Karter AJ, Konieczny JL, Steiner JF. Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases. Med Care. 2013;51(8 Suppl 3):S11-21. https:\/\/doi.org\/10.1097\/MLR.0b013e31829b1d2a.","journal-title":"Med Care"},{"key":"1904_CR16","doi-asserted-by":"publisher","unstructured":"Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008. 11(1):44\u20137. https:\/\/doi.org\/10.1111\/j.1524-4733.2007.00213.x","DOI":"10.1111\/j.1524-4733.2007.00213.x"},{"issue":"3","key":"1904_CR17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1547-5069.2003.tb00001.x","volume":"35","author":"PV Burkhart","year":"2003","unstructured":"Burkhart PV, Sabat\u00e9 E. Adherence to long-term therapies: evidence for action. J Nurs Scholarsh. 2003;35(3):207.","journal-title":"J Nurs Scholarsh"},{"issue":"1","key":"1904_CR18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s11883-012-0291-7","volume":"15","author":"P Maningat","year":"2013","unstructured":"Maningat P, Gordon BR, Breslow JL. How do we improve patient compliance and adherence to long-term statin therapy? Curr Atheroscler Rep. 2013;15(1):291. https:\/\/doi.org\/10.1007\/s11883-012-0291-7.","journal-title":"Curr Atheroscler Rep"},{"issue":"34","key":"1904_CR19","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1093\/eurheartj\/ehac015","volume":"43","author":"I Byty\u00e7i","year":"2022","unstructured":"Byty\u00e7i I, Penson PE, Mikhailidis DP, et al. Prevalence of statin intolerance: a meta-analysis. Eur Heart J. 2022;43(34):3213\u201323. https:\/\/doi.org\/10.1093\/eurheartj\/ehac015.","journal-title":"Eur Heart J"},{"issue":"7","key":"1904_CR20","doi-asserted-by":"publisher","first-page":"526","DOI":"10.7326\/0003-4819-158-7-201304020-00004","volume":"158","author":"H Zhang","year":"2013","unstructured":"Zhang H, Plutzky J, Skentzos S, et al. Discontinuation of statins in routine care settings: a cohort study. Ann Intern Med. 2013;158(7):526\u201334. https:\/\/doi.org\/10.7326\/0003-4819-158-7-201304020-00004.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1904_CR21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12872-020-01566-2","volume":"20","author":"B Zhao","year":"2020","unstructured":"Zhao B, He X, Wu J, Yan S. Adherence to statins and its impact on clinical outcomes: a retrospective population-based study in China. BMC Cardiovasc Disord. 2020;20(1):282. https:\/\/doi.org\/10.1186\/s12872-020-01566-2.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"1904_CR22","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.clinthera.2011.12.011","volume":"34","author":"L DegliEsposti","year":"2012","unstructured":"DegliEsposti L, Saragoni S, Batacchi P, et al. Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis. Clin Ther. 2012;34(1):190\u20139. https:\/\/doi.org\/10.1016\/j.clinthera.2011.12.011.","journal-title":"Clin Ther"},{"issue":"2","key":"1904_CR23","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.clinthera.2010.02.004","volume":"32","author":"G Corrao","year":"2010","unstructured":"Corrao G, Conti V, Merlino L, et al. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy. Clin Ther. 2010;32(2):300\u201310. https:\/\/doi.org\/10.1016\/j.clinthera.2010.02.004.","journal-title":"Clin Ther"},{"issue":"2","key":"1904_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191817","volume":"13","author":"V Fung","year":"2018","unstructured":"Fung V, Graetz I, Reed M, Jaffe MG. Patient-reported adherence to statin therapy, barriers to adherence, and perceptions of cardiovascular risk. PLoS ONE. 2018;13(2):e0191817. https:\/\/doi.org\/10.1371\/journal.pone.0191817.","journal-title":"PLoS ONE"},{"issue":"10","key":"1904_CR25","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.amjcard.2011.01.013","volume":"107","author":"A Kulik","year":"2011","unstructured":"Kulik A, Shrank WH, Levin R, Choudhry NK. Adherence to statin therapy in elderly patients after hospitalization for coronary revascularization. Am J Cardiol. 2011;107(10):1409\u201314. https:\/\/doi.org\/10.1016\/j.amjcard.2011.01.013.","journal-title":"Am J Cardiol"},{"issue":"11","key":"1904_CR26","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.18553\/jmcp.2018.24.11.1146","volume":"24","author":"H Kumamaru","year":"2018","unstructured":"Kumamaru H, Lee MP, Choudhry NK, et al. Using previous medication adherence to predict future adherence. J Manag Care Spec Pharm. 2018;24(11):1146\u201355. https:\/\/doi.org\/10.18553\/jmcp.2018.24.11.1146.","journal-title":"J Manag Care Spec Pharm"},{"issue":"2","key":"1904_CR27","doi-asserted-by":"publisher","first-page":"186","DOI":"10.18553\/jmcp.2021.27.2.186","volume":"27","author":"Z Majd","year":"2021","unstructured":"Majd Z, Mohan A, Paranjpe R, Abughosh SM. Identifying adherent patients to newly initiated statins using previous adherence to chronic medications. J Manag Care Spec Pharm. 2021;27(2):186\u201397. https:\/\/doi.org\/10.18553\/jmcp.2021.27.2.186.","journal-title":"J Manag Care Spec Pharm"},{"issue":"13","key":"1904_CR28","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.2147\/PPA.S231873","volume":"13","author":"M Alwhaibi","year":"2019","unstructured":"Alwhaibi M, Altoaimi M, AlRuthia Y, et al. Adherence to statin therapy and attainment of LDL cholesterol goal among patients with type 2 diabetes and dyslipidemia. Patient Prefer Adherence. 2019;13(13):2111\u20138. https:\/\/doi.org\/10.2147\/PPA.S231873.","journal-title":"Patient Prefer Adherence"},{"issue":"3","key":"1904_CR29","doi-asserted-by":"publisher","first-page":"595","DOI":"10.2337\/diacare.28.3.595","volume":"28","author":"ES Parris","year":"2005","unstructured":"Parris ES, Lawrence DB, Mohn LA, Long L. Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia. Diabetes Care. 2005;28(3):595\u20139. https:\/\/doi.org\/10.2337\/diacare.28.3.595.","journal-title":"Diabetes Care"},{"issue":"16","key":"1904_CR30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2147\/PPA.S340573","volume":"21","author":"S Yao","year":"2022","unstructured":"Yao S, Lix L, Teare G, Evans C, Blackburn D. The impact of age and sex concordance between patients and physicians on medication adherence: a population-based study. Patient Prefer Adherence. 2022;21(16):169\u201378. https:\/\/doi.org\/10.2147\/PPA.S340573.","journal-title":"Patient Prefer Adherence"},{"key":"1904_CR31","doi-asserted-by":"publisher","unstructured":"La Fauci V, Alessi V, Assefa DZ, Lo Giudice D, Calimeri S, Ceccio C, et al. Mediterranean diet: knowledge and adherence in Italian young people. Clin Ter. 2020;171(5):e437\u201343. https:\/\/doi.org\/10.7417\/CT.2020.2254","DOI":"10.7417\/CT.2020.2254"},{"issue":"5","key":"1904_CR32","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.amjmed.2020.09.058","volume":"134","author":"G Lavie","year":"2021","unstructured":"Lavie G, Hoshen M, Leibowitz M, et al. Statin therapy for primary prevention in the elderly and its association with new-onset diabetes, cardiovascular events, and all-cause mortality. Am J Med. 2021;134(5):643\u201352. https:\/\/doi.org\/10.1016\/j.amjmed.2020.09.058.","journal-title":"Am J Med"},{"key":"1904_CR33","doi-asserted-by":"publisher","unstructured":"Kim S, Choi H, Won CW. Moderate-intensity statin use for primary prevention for more than 5 years is associated with decreased all-cause mortality in 75 years and older. Arch Gerontol Geriatr. 2022;100:104644. https:\/\/doi.org\/10.1016\/j.archger.2022.104644","DOI":"10.1016\/j.archger.2022.104644"},{"issue":"1","key":"1904_CR34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12916-021-02009-1","volume":"19","author":"K Awad","year":"2021","unstructured":"Awad K, Mohammed M, Zaki MM, et al. Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies. BMC Med. 2021;19(1):139. https:\/\/doi.org\/10.1186\/s12916-021-02009-1.","journal-title":"BMC Med"},{"key":"1904_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.maturitas.2019.03.011","volume":"124","author":"P Anagnostis","year":"2019","unstructured":"Anagnostis P, Vaitsi K, Veneti S, et al. Management of dyslipidaemias in the elderly population: a narrative review. Maturitas. 2019;124:93\u20139. https:\/\/doi.org\/10.1016\/j.maturitas.2019.03.011.","journal-title":"Maturitas"},{"issue":"4","key":"1904_CR36","first-page":"393","volume":"40","author":"L Palmieri","year":"2004","unstructured":"Palmieri L, Panico S, Vanuzzo D, et al. La valutazione del rischio cardiovascolare globale assoluto: il punteggio individuale del Progetto CUORE. Ann Ist Super Sanit\u00e0. 2004;40(4):393\u20139.","journal-title":"Ann Ist Super Sanit\u00e0"},{"issue":"3","key":"1904_CR37","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/17512433.2020.1734451","volume":"13","author":"JV Pergolizzi Jr","year":"2020","unstructured":"Pergolizzi JV Jr, Coluzzi F, Colucci RD, et al. Statins and muscle pain. Expert Rev Clin Pharmacol. 2020;13(3):299\u2013310. https:\/\/doi.org\/10.1080\/17512433.2020.1734451.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"2","key":"1904_CR38","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1161\/ATV.0000000000000073","volume":"39","author":"CB Newman","year":"2019","unstructured":"Newman CB, Preiss D, Tobert JA, et al. Statin safety and associated adverse events: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol. 2019;39(2):e38\u201381. https:\/\/doi.org\/10.1161\/ATV.0000000000000073.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"20","key":"1904_CR39","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1016\/j.jacc.2016.02.071","volume":"67","author":"PD Thompson","year":"2016","unstructured":"Thompson PD, Panza G, Zaleski A, Taylor B. Statin-associated side effects. J Am Coll Cardiol. 2016;67(20):2395\u2013410. https:\/\/doi.org\/10.1016\/j.jacc.2016.02.071.","journal-title":"J Am Coll Cardiol"},{"issue":"10355","key":"1904_CR40","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/S0140-6736(22)01545-8","volume":"400","author":"CTT Collaboration","year":"2022","unstructured":"Collaboration CTT. Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials. Lancet. 2022;400(10355):832\u201345. https:\/\/doi.org\/10.1016\/S0140-6736(22)01545-8.","journal-title":"Lancet"},{"key":"1904_CR41","doi-asserted-by":"publisher","unstructured":"de La Harpe R, Muzambi R, Bhaskaran K, Eastwood S, Herrett E. Inequities in statin adherence for primary prevention of cardiovascular disease: a historical cohort study in English primary care. Eur J Prev Cardiol. 2025;219. https:\/\/doi.org\/10.1093\/eurjpc\/zwaf219.","DOI":"10.1093\/eurjpc\/zwaf219"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-026-01904-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-026-01904-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-026-01904-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:21:08Z","timestamp":1790655668000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-026-01904-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1904"],"URL":"https:\/\/doi.org\/10.1007\/s13300-026-01904-1","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the original Declaration of Helsinki and further amendments, and it was approved by the Scientific Review Committee of Nefrocenter Research and the Ethics Committee of \u201cCampania South\u201d Local Health Authority (protocol code no. code no. 66118, 10 March 2026), as the ethics committee of reference for all the territorial structures participating in the study. All collaborating canters refers to the Scientific Review Committee of Nefrocenter Research and the Ethics Committee of \u201cCampania South\u201d Local Health Authority. The use of Nefro-Bank data has been previously authorized by the Board of Directors of Nefrocenter Research. Previous consent was obtained from all subjects registered in the clinic records to use data from research.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Felice Strollo and Sandro Gentile are editorial board members of Diabetes Therapy. Felice Strollo and Sandro Gentile were not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. The following authors\u2014Giuseppina Guarino, Ersilia Satta, Giuseppe Caccavale, Maria Chiarello, Rosina De Luca, Roberta Di Martino, Carmine Romano, Maria Carla Sibilio, and Raffaele Marfella\u2014have nothing to disclose.","order":2,"name":"Ethics","label":"Conflicts of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}